Skip to main content

Hard palate perforation in acute lymphoblastic leukemia due to mucormycosis — a case report

Abstract

Palatal perforation can occur due to trauma, infection and malignancy. Mucormycosis is a rare opportunistic fungal infection caused by an organism of class zygomycetes. Rhinocerebral mucormycosis is the most common type of mucormycosis that typically starts in maxillary antrum in immunocompromised patients. Invasion of surrounding structures leads to necrotizing ulcer of the hard palate and ultimately leads to perforation. Here, we report a case of perforation of the hard palate due to mucormycosis in a eight years child having acute lymphoblastic leukemia (ALL), who was on prolonged chemotherapy and corticosteroid therapy. This case is being reported for its rarity. The aim of presenting this case report is to emphasize that the infection due to mucomycosis should be included in the differential diagnosis of hard palate perforation in ALL patients who are immunocompromised.

This is a preview of subscription content, access via your institution.

Refferences

  1. 1.

    Jayachandran S, Krithika C (2006) Mucormycosis presenting as palatal Perforation. Indian J Dental Res 17:139–142

    CAS  Article  Google Scholar 

  2. 2.

    Leitner C, Hoffmann J, Zerfowski M, Reinert S (2003) Mucormycosis: necrotising soft tissue lesion of the face. J Oral Maxillofac Surg 61:1354–1358

    PubMed  Article  Google Scholar 

  3. 3.

    Sugar AM (2000) Agents of mucormycosis and related species. In: Mandell G, Bennett J, Dolin R. (5th ed.) Principles and practices of infectious diseases. Churchill Livingstone, Philadelphia New York, pp 2685–2695

    Google Scholar 

  4. 4.

    Pogrel MA, Miller CE (2003) A case of maxillary necrosis. J Oral Maxillofac Surg 61:489–493

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Regezi JA, Sciubba JJ (1993) Ulcerative conditions. In: Regezi JA, Sciubba JJ (2nd ed.) Oral pathology clinical pathological correlations. W B Saunders, Philadelphia, pp 52–60

    Google Scholar 

  6. 6.

    Plataut AP (1885) Mucosis mucorina. Virchows Arch 102: 543–564

    Article  Google Scholar 

  7. 7.

    Mowat AG, Baum J (1971) Chemotaxis of polymorphonuclear leucocytes from patients with diabetes mellitus. New Engl J Med 284:621–627

    PubMed  CAS  Google Scholar 

  8. 8.

    Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, Cenacchi A, Pacilli L, Fabbiano F, Favero AD (2003) Mucormycosis in patients with haematological malignancies: A retrospective clinical study of 37 cases. Br J Haematol 99:331–336

    Article  Google Scholar 

  9. 9.

    Fain JK, Markowitz A, Khilanani PV (1978) Case report of localized mucormycosis following intramuscular corticosteroid. Am J Med Sci 275:209–216

    Google Scholar 

  10. 10.

    Daly AL, Velazquez LA, Barkley SF, Kauff CA (1989) Mucormycosis: association with deferroxamine therapy. Am J Med 87:468–471

    PubMed  CAS  Article  Google Scholar 

  11. 11.

    Diamond RD, Haudenschild CC, Erickson NF (1982) Monocyte mediated damage to rhizopus oryzae hyphae in vitro. Infect Immun 38:292–297

    PubMed  CAS  Google Scholar 

  12. 12.

    Chinn RY, Diamond RD (1982) Generation of chemotatic factors by rhizopus oryzae in the presence and absence of serum: Relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun 38:1123–1129

    PubMed  CAS  Google Scholar 

  13. 13.

    Waldorf AR, Ruderman N, Diamond RD (1984) Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defence against rhizopus. J Clin Invest 74:150–160

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Marr KA, Carter RA, Crippa F, Wald A, Corey L (2002) Epidemiology and outcome of mould infections in haemopoietic stem cell transplant recipients. Clin Infect Dis 34: 909–917

    PubMed  Article  Google Scholar 

  15. 15.

    Rickerts V, Böhme A, Just-Nübling G (2002) Risk factors for invasive zygomycosis in patients with hematological malignancies. Mycoses 45(suppl. 1):27–33

    PubMed  Google Scholar 

  16. 16.

    Petrikkos G, Skiada A, Sambatakou H, Toskas A, Valopoulos G, Giannopoulou M, Katsilambros N (2003) Mucormycosis: ten years experience at a tertiary care centre in Greece. Eur J Clin Microbiol Infect Disease 22:753–756

    Article  CAS  Google Scholar 

  17. 17.

    Seyer B, Grist W, Miller S. (2002) Palatal perforation in long term intranasal cocaine abuse. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:465–470

    PubMed  Article  Google Scholar 

  18. 18.

    Loudon JA, Marsh WE, Allen CM. (2000) Destructive midline palatal lesion. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89:134–136

    PubMed  Article  CAS  Google Scholar 

  19. 19.

    Ribes JA, Vanover-Sams CL, Baker DJ. (2000), Zygomycetes in human Disease. Clin Microbiol Rev 13:236–301

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Dipti R. Samanta.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Samanta, D.R., Senapati, S.N., Sharma, P.K. et al. Hard palate perforation in acute lymphoblastic leukemia due to mucormycosis — a case report. Indian J Hematol Blood Transfus 25, 36–39 (2009). https://doi.org/10.1007/s12288-009-0009-3

Download citation

Keywords

  • Hard palate perforation
  • Mucormycosis
  • Acute lymphoblastic leukemia
  • Immunocompromised